Clincosm LogoSign in Get a demo

Obesity

Showing NaN - NaN of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity Trial in United States (Cagrilintide, Semaglutide, Tirzepatide)

Not yet recruiting
  • Obesity
  • Birmingham, Alabama
  • +44 more
Nov 9, 2023

Type 2 Diabetes, Obesity, Overweight Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • +3 more
  • Los Angeles, California
  • +91 more
Jul 10, 2023

Obesity, Overweight, Knee Pain Chronic Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • +4 more
  • Phoenix, Arizona
  • +168 more
Jul 10, 2023

Obesity, Cardiovascular Diseases Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • Cardiovascular Diseases
  • Phoenix, Arizona
  • +165 more
May 22, 2023

Obesity, Overweight, Overweight or Obesity Trial in Worldwide (Orforglipron, Placebo)

Not yet recruiting
  • Obesity
  • +2 more
  • Mesa, Arizona
  • +134 more
May 12, 2023

Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)

Recruiting
  • Type 2 Diabetes
  • +5 more
  • Muscle Shoals, Alabama
  • +320 more
Apr 12, 2023

Sleep Apnea, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Sleep Apnea
  • Obesity
  • Riverside, California
  • +66 more
Jan 23, 2023

Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

Not yet recruiting
  • Overweight
  • +2 more
  • Concord, California
  • +147 more
Jan 24, 2023

Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)

Recruiting
  • Obesity
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +73 more
Jan 24, 2023

Obesity Trial in Worldwide (Semaglutide, Placebo)

Recruiting
  • Obesity
  • Birmingham, Alabama
  • +106 more
Jan 24, 2023

Diabetes, Obesity Trial in Worldwide (PF-07081532, Placebo, Rybelsus)

Recruiting
  • Diabetes Mellitus
  • Obesity
  • Centreville, Alabama
  • +55 more
Jan 18, 2023

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Obesity
  • Overweight
  • Gilbert, Arizona
  • +695 more
Jan 18, 2023

Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +804 more
Dec 19, 2022

Obesity Trial in La Jolla, Austin, Coleraine (VeSTAL)

Completed
  • Obesity
  • VeSTAL
  • La Jolla, California
  • +3 more
Aug 8, 2022

Pregnancy Related, Obesity, Labor Onset and Length Abnormalities Trial in Austin (50 Micrograms Vaginal Misoprostol

Recruiting
  • Pregnancy Related
  • +2 more
  • 50 Micrograms Vaginal Misoprostol (Intervention)
  • 25 Micrograms Vaginal Misoprostol (Control)
  • Austin, Texas
    University of Texas at Austin Dell Medical School, Department of
Jun 2, 2022

Obesity, Overweight Trial in Puerto Rico, United States (LY3437943, Placebo)

Active, not recruiting
  • Obesity
  • Overweight
  • Scottsdale, Arizona
  • +27 more
May 10, 2022

Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • +2 more
  • Birmingham, Alabama
  • +74 more
Apr 18, 2022

Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Overweight
  • Obesity
  • Pelham, Alabama
  • +119 more
Apr 12, 2022

Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (Semaglutide))

Completed
Has Results
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +40 more
Mar 21, 2022

Overweight, Obesity Trial in United States

Recruiting
  • Overweight
  • Obesity
    • Little Rock, Arkansas
    • +27 more
    Feb 11, 2022

    Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (Semaglutide, Placebo)

    Completed
    Has Results
    • Metabolism and Nutrition Disorder
    • Obesity
    • Anniston, Alabama
    • +71 more
    Jan 7, 2022

    Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide))

    Completed
    Has Results
    • Overweight
    • Obesity
    • Birmingham, Alabama
    • +40 more
    Nov 10, 2021

    Obesity, Overweight Trial in Worldwide (Semaglutide 1.0 mg, Semaglutide 2.4 mg, Placebo I (Semaglutide))

    Completed
    Has Results
    • Obesity
    • Overweight
    • Semaglutide 1.0 mg
    • +3 more
    • Buena Park, California
    • +146 more
    Nov 8, 2021

    Obesity Trial in United States (Intervention)

    Completed
    • Obesity
    • Intervention
    • Austin, Texas
    • +15 more
    Sep 29, 2021

    Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (Liraglutide 3.0 mg, Placebo)

    Completed
    Has Results
    • Metabolism and Nutrition Disorder
    • Obesity
    • Liraglutide 3.0 mg
    • Placebo
    • Birmingham, Alabama
    • +53 more
    Mar 13, 2020